Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Inventory (2016 - 2025)

Immucell (ICCC) has disclosed Inventory for 16 consecutive years, with $9.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory rose 31.39% year-over-year to $9.8 million, compared with a TTM value of $9.8 million through Sep 2025, up 31.39%, and an annual FY2024 reading of $7.1 million, down 8.95% over the prior year.
  • Inventory was $9.8 million for Q3 2025 at Immucell, up from $8.3 million in the prior quarter.
  • Across five years, Inventory topped out at $9.8 million in Q3 2025 and bottomed at $2.1 million in Q1 2021.
  • Average Inventory over 5 years is $6.0 million, with a median of $7.1 million recorded in 2024.
  • The sharpest move saw Inventory soared 99.39% in 2022, then decreased 8.95% in 2024.
  • Year by year, Inventory stood at $3.1 million in 2021, then surged by 95.42% to $6.0 million in 2022, then grew by 29.37% to $7.8 million in 2023, then fell by 8.95% to $7.1 million in 2024, then surged by 37.81% to $9.8 million in 2025.
  • Business Quant data shows Inventory for ICCC at $9.8 million in Q3 2025, $8.3 million in Q2 2025, and $7.4 million in Q1 2025.